| |
|
|
|
Xtalks, Online
2025-10-28
Targeted delivery enhances the safety and efficacy of small nucleic acid drugs. By conjugating siRNA or antisense oligonucleotides (ASOs) with targeting molecules, such as antibodies or peptides, cellular uptake, stability and bioavailability are improved, while immunogenicity and toxicity are reduced.
In this webinar, the featured speakers will introduce technical solutions and application cases for small RNA drug conjugation, focusing on conjugate product identification, precise delivery and gene silencing, as well as differences across methods, offering new insights to boost research efficiency.
The topics that will be covered in this webinar include:
Advances in Small Nucleic Acid Drug Delivery
Ligand-Mediated Extrahepatic Delivery Techniques
Advantages of DAR 1 Antibody-siRNA Conjugate
Conjugation Solutions for Accelerating Precise Targeted Delivery
Register for this webinar to learn how conjugation strategies are shaping the future of small nucleic acid drug delivery.
Keywords: Antibody Drug, Antibody-Drug Conjugate, Antisense Oligonucleotides, Basic Research, Biologics, Biologics Development, CRO, Drug Delivery, Drug Development, PK, Pre-Clinical, RNA, siRNA, Small Molecule, Small Nucleic Acid Drug
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Jacob Guo, PhD, Director, Nucleic Acid Platform, R&D Dept., GenScript Biotech Corporation
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-10-28
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|